Cargando…

Association between a biomarker of glucose spikes, 1,5-anhydroglucitol, and cancer mortality

INTRODUCTION: 1,5-Anhydroglucitol (1,5-AG) is a biomarker of glucose spikes. To evaluate the effect of acute glucose excursions on cancer death, we clarified the association between 1,5-AG and cancer mortality among Japanese individuals with normal glucose tolerance. RESEARCH DESIGN AND METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kira, Sakurako, Ito, Chikako, Fujikawa, Rumi, Misumi, Munechika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Epidemiology/Health services research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430336/ https://www.ncbi.nlm.nih.gov/pubmed/32792354 http://dx.doi.org/10.1136/bmjdrc-2020-001607

Ejemplares similares

Increased cancer mortality among Japanese individuals with hyperinsulinemia
por: Kira, Sakurako, et al.
Publicado: (2020)

Longitudinal examination of pancreatic β‐cell function in Japanese individuals
por: Fujikawa, Rumi, et al.
Publicado: (2019)

Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality
por: Selvin, Elizabeth, et al.
Publicado: (2016)

Data for serum 1,5 anhydroglucitol concentration in different populations
por: Welter, Marciane, et al.
Publicado: (2018)

1,5-Anhydroglucitol Predicts Mortality in Patients with HBV-Related Acute-on-chronic Liver Failure
por: Zhang, Lingjian, et al.
Publicado: (2022)

Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol
por: Lee, Ji-Eun
Publicado: (2015)

Association of 1,5-Anhydroglucitol and 2-h Postprandial Blood Glucose in Type 2 Diabetic Patients
por: Stettler, Christoph, et al.
Publicado: (2008)

1,5-Anhydroglucitol as a Marker of Acute Hyperglycemia in Cardiovascular Events
por: Migała, Marta, et al.
Publicado: (2022)

Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population
por: Inoue, Kosuke, et al.
Publicado: (2021)

Genome-wide association study of 1,5-anhydroglucitol identifies novel genetic loci linked to glucose metabolism
por: Li, Man, et al.
Publicado: (2017)

Mortality among individuals exposed to atomic bomb radiation in utero: 1950–2012
por: Sugiyama, Hiromi, et al.
Publicado: (2021)

The risk of total mortality and cardiovascular mortality associated with impaired glucose regulation in Tayside, Scotland, UK: a record-linkage study in 214 094 people
por: Evans, Josie M M, et al.
Publicado: (2015)

Value of serum 1,5-anhydroglucitol measurements in childhood obesity in the continuum of diabetes
por: Yoo, Ha Yeong, et al.
Publicado: (2015)

Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers
por: Malkan, Umit Yavuz, et al.
Publicado: (2015)

Salivary 1,5-Anhydroglucitol and Vitamin Levels in Relation to Caries Risk in Children
por: Syed, Sadatullah, et al.
Publicado: (2019)

Finding the clinical utility of 1,5-anhydroglucitol among primary care practitioners
por: Peabody, John, et al.
Publicado: (2020)

Risk of morbidity and mortality in patients with type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor and/or dipeptidyl peptidase-4 inhibitor: a nationwide study
por: Sütő, Gábor, et al.
Publicado: (2021)

Random plasma glucose levels and cause-specific mortality among Chinese adults without known diabetes: an 11-year prospective study of 450,000 people
por: Vermunt, Jane, et al.
Publicado: (2021)

Serum 1,5-anhydroglucitol when used with fasting plasma glucose improves the efficiency of diabetes screening in a Chinese population
por: Ying, Lingwen, et al.
Publicado: (2017)

Clinical implication of blood glucose monitoring in general dental offices: the Ehime Dental Diabetes Study
por: Harase, Tadahiro, et al.
Publicado: (2015)

Hemoglobin A1c in combination with fasting plasma glucose trumps fasting plasma glucose alone as predictive indicators for diabetes mellitus: an ambidirectional cohort study of Thai people with impaired fasting glucose
por: Thamakaison, Sangsulee, et al.
Publicado: (2021)

Variations in all-cause mortality, premature mortality and cause-specific mortality among persons with diabetes in Ontario, Canada
por: Rosella, Laura C, et al.
Publicado: (2023)

Evaluation of Serum 1,5 Anhydroglucitol Levels as a Clinical Test to Differentiate Subtypes of Diabetes
por: Pal, Aparna, et al.
Publicado: (2010)

Measurement of 1,5-anhydroglucitol in blood and saliva: from non-targeted metabolomics to biochemical assay
por: Halama, Anna, et al.
Publicado: (2016)

Relationship of glycemic control markers - 1,5 anhydroglucitol, fructosamine, and glycated hemoglobin among Asian Indians with different degrees of glucose intolerance
por: Pramodkumar, Thyparambil Aravindakshan, et al.
Publicado: (2016)

Bimodal Distribution of Glucose Is Not Universally Useful for Diagnosing Diabetes
por: Vistisen, Dorte, et al.
Publicado: (2009)

30-minute postload plasma glucose levels during an oral glucose tolerance test predict the risk of future type 2 diabetes: the Hisayama Study
por: Hirakawa, Yoichiro, et al.
Publicado: (2020)

Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis
por: Tanaka, Kenji, et al.
Publicado: (2021)

Glucose Peaks and the Risk of Dementia and 20-Year Cognitive Decline
por: Rawlings, Andreea M., et al.
Publicado: (2017)

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes
por: Aleppo, Grazia, et al.
Publicado: (2017)

Prevalence and Control of Diabetes and Impaired Fasting Glucose in New York City
por: Thorpe, Lorna E., et al.
Publicado: (2009)

Sleep Disturbances and Glucose Metabolism in Older Adults: The Cardiovascular Health Study
por: Strand, Linn Beate, et al.
Publicado: (2015)

Exploring abnormal glucose metabolism in pregnancy among Australian Chinese migrants
por: Li, Ling-Jun, et al.
Publicado: (2020)

Population-Level Impact and Cost-effectiveness of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring Technologies for Adults With Type 1 Diabetes in Canada: A Modeling Study
por: Rotondi, Michael A., et al.
Publicado: (2022)

SGLT5 is the renal transporter for 1,5-anhydroglucitol, a major player in two rare forms of neutropenia
por: Diederich, Jennifer, et al.
Publicado: (2023)

Mining treatment patterns of glucose-lowering medications for type 2 diabetes in the Netherlands
por: van den Heuvel, Jan Maurik, et al.
Publicado: (2020)

Effect of 1,5-anhydroglucitol levels on culprit plaque rupture in diabetic patients with acute coronary syndrome
por: Su, Gong, et al.
Publicado: (2020)

Salivary 1,5-Anhydroglucitol and its Correlation with Postprandial Hyperglycemia: Development and Validation of a Novel Assay
por: Kedarnath, Priyadarshini Subramaniam, et al.
Publicado: (2023)

Empirically Establishing Blood Glucose Targets to Achieve HbA(1c) Goals
por: Wei, Nancy, et al.
Publicado: (2014)

Association of glucose variability at the last day of hospitalization with 30-day readmission in adults with diabetes
por: Spanakis, Elias K, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lp1ks7tdmpqb4kgtrk7cib5d6t